Kings Point Capital Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
$50K Hold
206
﹤0.01% 346
2021
Q4
$54K Sell
206
-174
-46% -$45.2K ﹤0.01% 375
2021
Q3
$100K Hold
380
0.01% 275
2021
Q2
$94K Buy
380
+174
+84% +$36.6K 0.01% 278
2021
Q1
$40K Hold
206
﹤0.01% 363
2020
Q4
$44K Hold
206
﹤0.01% 329
2020
Q3
$35K Hold
206
﹤0.01% 347
2020
Q2
$40K Hold
206
0.01% 297
2020
Q1
$30K Hold
206
0.01% 329
2019
Q4
$32K Hold
206
﹤0.01% 368
2019
Q3
$28K Hold
206
﹤0.01% 361
2019
Q2
$25K Hold
206
﹤0.01% 328
2019
Q1
$21K Hold
206
﹤0.01% 303
2018
Q4
$23K Hold
206
0.01% 297
2018
Q3
$24K Hold
206
﹤0.01% 306
2018
Q2
$21K Hold
206
﹤0.01% 311
2018
Q1
$20K Hold
206
﹤0.01% 318
2017
Q4
$17K Hold
206
﹤0.01% 329
2017
Q3
$16K Hold
206
﹤0.01% 319
2017
Q2
$16K Hold
206
﹤0.01% 300
2017
Q1
$15K Hold
206
﹤0.01% 318
2016
Q4
$13K Hold
206
﹤0.01% 291
2016
Q3
$13K Hold
206
﹤0.01% 286
2016
Q2
$13K Hold
206
﹤0.01% 301
2016
Q1
$12K Hold
206
﹤0.01% 309
2015
Q4
$11K Hold
206
﹤0.01% 344
2015
Q3
$10K Hold
206
﹤0.01% 367
2015
Q2
$12K Hold
206
﹤0.01% 338
2015
Q1
$15K Hold
206
﹤0.01% 328
2014
Q4
$12K Hold
206
﹤0.01% 329
2014
Q3
$10K Hold
206
﹤0.01% 312
2014
Q2
$10K Buy
+206
New +$10.2K ﹤0.01% 323

Other funds holding RMD

Kings Point Capital Management's RMD Position: Q1 2022 in Review

Kings Point Capital Management held its ResMed (RMD) position steady in Q1 2022 at 206 shares worth $50K. The position accounts for ﹤0.01% of the portfolio, ranked #346.

Kings Point Capital Management first reported a position in RMD in Q2 2014 and has held it in 32 quarters since. The position peaked at $100K in Q3 2021. 682 funds tracked by Wall St. Rank hold RMD as of Q1 2022.

  • Kings Point Capital Management held 206 shares of ResMed worth $50K as of Q1 2022.
  • Kings Point Capital Management left its ResMed share count unchanged in Q1 2022.
  • ResMed made up ﹤0.01% of Kings Point Capital Management's portfolio in Q1 2022, its #346 holding.
  • Kings Point Capital Management first reported a position in ResMed in Q2 2014 and has held it in 32 quarters since.
  • Kings Point Capital Management's ResMed position peaked at $100K in Q3 2021.
  • 682 funds tracked by Wall St. Rank held ResMed as of Q1 2022.

Based on Kings Point Capital Management's 13F filing for Q1 2022, filed 13 May 2022.